0001104659-23-023388.txt : 20230217 0001104659-23-023388.hdr.sgml : 20230217 20230217182108 ACCESSION NUMBER: 0001104659-23-023388 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYCE RICHARD PAUL CENTRAL INDEX KEY: 0001553037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40356 FILM NUMBER: 23644480 MAIL ADDRESS: STREET 1: C/O PUMA BIOTECHNOLOGY, INC. STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rain Oncology Inc. CENTRAL INDEX KEY: 0001724979 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821130967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: (510) 953-5559 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: Rain Therapeutics Inc. DATE OF NAME CHANGE: 20171211 4 1 tm237300-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-02-15 0 0001724979 Rain Oncology Inc. RAIN 0001553037 BRYCE RICHARD PAUL C/O RAIN ONCOLOGY INC. 8000 JARVIS AVENUE, SUITE 204 NEWARK CA 94560 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 9.30 2023-02-15 4 A 0 110000 0.00 A 2033-02-15 Common Stock 110000 110000 D This option represents a right to purchase a total of 110,000 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer. /s/ Nelson Cabatuan, Attorney-in-fact for Richard Bryce 2023-02-17